Universal Ibogaine Inc. (IBO.V)

CAD 0.02

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2022 2021 2020 2019 2018
Revenue 1.07 Million - - - -
Cost of Revenue - - - - -
Gross Profit 1.07 Million - - - -
Operating Expenses 5.81 Million 3.86 Million 59.24 Thousand 68.85 Thousand 176.22 Thousand
Selling, General and Administrative Expenses 4.56 Million 3.73 Million 58.98 Thousand 68.85 Thousand 176.22 Thousand
Research and Development Expenses 409.31 Thousand 63.19 Thousand - - -
Other Expenses -127.54 Thousand - - - -
Cost and Expenses 5.81 Million 3.86 Million 59.24 Thousand 68.85 Thousand 176.22 Thousand
Operating Income 497.15 Thousand -3.83 Million 383.00 -33.86 Thousand 63.95 Thousand
Interest Expense 67.74 Thousand 15 Thousand - - -
Income Tax Expense -59.8 Thousand 15 Thousand 59.06 Thousand - -
Earnings before Tax -10.49 Million -3.86 Million -118.3 Thousand -98.1 Thousand -408.28 Thousand
Net Income -10.49 Million -3.86 Million -118.3 Thousand -98.1 Thousand -408.28 Thousand
Earnings Per Share Basic -0.06 -0.03 -0.01 -0.01 -0.04
Earnings Per Share Diluted -0.06 -0.03 -0.01 -0.01 -0.04
Weighted Average Shares Outstanding 185.63 Million 125.18 Million 11.83 Million 9.81 Million 10.2 Million
Weighted Average Shares Outstanding (Diluted) 185.63 Million 125.18 Million 11.83 Million 9.81 Million 10.2 Million
Gross Margin 1.00 - - - -
EBIT Margin -4.30 - - - -
Profit Margin -9.80 - - - -
EBITDA -4.6 Million -3.76 Million 638.00 -33.86 Thousand 63.95 Thousand
Earnings Before Tax Margin 0.46 - - - -

Income Statement Charts